Picture of Biosyent logo

RX Biosyent Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Annual income statement for Biosyent, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue20.821.521.422.328.6
Cost of Revenue
Gross Profit1616.616.617.422.6
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses14.314.71617.320.4
Operating Profit6.446.795.395.038.18
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes6.857.555.875.248.38
Provision for Income Taxes
Net Income After Taxes5.215.714.373.86.28
Net Income Before Extraordinary Items
Net Income5.215.714.373.86.28
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income5.215.714.373.86.28
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.360.3960.360.290.488

Or unlock with your email

Or unlock with your email